Structure and functions of angiotensinogen.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26888118)

Published in Hypertens Res on February 18, 2016

Authors

Hong Lu1,2, Lisa A Cassis3, Craig W Vander Kooi4, Alan Daugherty1,2,3

Author Affiliations

1: Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.
2: Department of Physiology, University of Kentucky, Lexington, KY, USA.
3: Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
4: Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.

Articles cited by this

ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics (2003) 7.83

Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07

DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis (2000) 5.09

Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A (1995) 3.54

Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A (1995) 3.46

Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature (1995) 3.23

Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature (1995) 3.06

Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol (2012) 2.58

Weight loss and the renin-angiotensin-aldosterone system. Hypertension (2005) 2.58

The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab (2010) 2.26

Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A (1998) 2.17

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol (2004) 2.11

Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem (1995) 2.11

Angiotensinogen-deficient mice with hypotension. J Biol Chem (1994) 2.11

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J (2001) 2.09

Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation (2004) 2.04

Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol (2006) 1.85

Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol (2011) 1.79

Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension (2002) 1.72

Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest (2008) 1.70

Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest (1996) 1.59

Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology (2001) 1.57

Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem (1993) 1.53

Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice. J Hypertens (2010) 1.52

Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A (2008) 1.51

A redox switch in angiotensinogen modulates angiotensin release. Nature (2010) 1.50

Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab (2007) 1.39

Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem (2000) 1.38

Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29

Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol (1998) 1.25

Local adipose tissue renin-angiotensin system. Curr Hypertens Rep (2008) 1.23

Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem (1994) 1.22

Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens (2010) 1.22

Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension (2012) 1.21

Genetic ablation of angiotensinogen in the subfornical organ of the brain prevents the central angiotensinergic pressor response. Circ Res (2006) 1.20

Increased adipose angiotensinogen gene expression in human obesity. Obes Res (2000) 1.11

Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest (1996) 1.11

Location and regulation of rat angiotensinogen messenger RNA. Hypertension (1988) 1.08

Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem (1994) 1.07

Tissue-specific expression of the human renin gene in transgenic mice. Biochem Biophys Res Commun (1989) 1.05

Atherosclerosis and arterial blood pressure in mice. Curr Drug Targets (2007) 1.05

Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br J Pharmacol (2009) 1.05

Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol (1997) 1.03

Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol (2012) 1.03

Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system. Lab Invest (1997) 1.01

Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice. J Hypertens (2010) 0.99

Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res (1992) 0.99

Deletion of angiotensin II type I receptor reduces hepatic steatosis. J Hepatol (2009) 0.98

The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord (2000) 0.96

Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension (2000) 0.95

Linkage analysis with candidate genes: the Taiwan young-onset hypertension genetic study. Hum Genet (2000) 0.95

Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice. Cancer Res (2009) 0.94

A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G. Am J Physiol Regul Integr Comp Physiol (2008) 0.93

Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J (2008) 0.93

Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice. Nephrol Dial Transplant (2010) 0.92

Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension (1998) 0.92

Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension. Hypertens Res (2013) 0.92

Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat Med (1998) 0.91

Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens (2000) 0.91

Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program. National Heart, Lung and Blood Institute. J Hypertens (2000) 0.91

AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol (2000) 0.89

Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen. Mol Ther (2006) 0.88

Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review. N Am J Med Sci (Boston) (2011) 0.88

Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. Cardiovasc Res (2010) 0.88

Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett (1998) 0.87

Effects of high-fat diet, angiotensinogen (agt) gene inactivation, and targeted expression to adipose tissue on lipid metabolism and renal gene expression. Horm Metab Res (2003) 0.87

Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane. J Mol Med (Berl) (2006) 0.87

Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet (1997) 0.87

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals. Hypertens Res (2014) 0.86

Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure. Am J Hypertens (1999) 0.86

Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One (2012) 0.86

Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project. J Hypertens (1999) 0.86

Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo. Hypertension (2015) 0.86

Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model. FASEB J (2015) 0.86

Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice. Metab Syndr Relat Disord (2014) 0.85

Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.83

Angiotensinogen Exerts Effects Independent of Angiotensin II. Arterioscler Thromb Vasc Biol (2015) 0.83

Dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor. Arterioscler Thromb Vasc Biol (2009) 0.83

Differential effects of dietary sodium intake on blood pressure and atherosclerosis in hypercholesterolemic mice. J Nutr Biochem (2012) 0.83

Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases. Future Lipidol (2008) 0.83

PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS One (2013) 0.82

Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice. Cardiovasc Drugs Ther (2011) 0.82

Inactivation of adipose angiotensinogen reduces adipose tissue macrophages and increases metabolic activity. Obesity (Silver Spring) (2015) 0.81

Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor. Clin Sci (Lond) (2013) 0.81

Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens (2000) 0.80

Establishing a reliable multiple reaction monitoring-based method for the quantification of obesity-associated comorbidities in serum and adipose tissue requires intensive clinical validation. J Proteome Res (2014) 0.80

Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension (2015) 0.80

Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life. Hypertens Res (2015) 0.79

Late-onset obesity in mice transgenic for the human renin gene. Int J Mol Med (2003) 0.79

Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen. Curr Hypertens Rep (2003) 0.79

Significant role of the increase in renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in double transgenic tsukuba hypertensive mice carrying both human renin and angiotensinogen genes. Clin Exp Hypertens (1998) 0.78

Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2. Am J Physiol Renal Physiol (2014) 0.77

Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice. J Renin Angiotensin Aldosterone Syst (2014) 0.76

Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARγ). J Physiol Pharmacol (2011) 0.76

Increased cardiac angiotensin II receptors in angiotensinogen-deficient mice. Hypertension (1998) 0.75